美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA207626"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
60290-046-03 60290-046 HUMAN PRESCRIPTION DRUG Rosuvastatin Calcium Rosuvastatin Calcium TABLET ORAL 20251011 N/A ANDA ANDA207626 Umedica Laboratories USA Inc. ROSUVASTATIN CALCIUM 40 mg/1 500 TABLET in 1 BOTTLE (60290-046-03)
60290-046-05 60290-046 HUMAN PRESCRIPTION DRUG Rosuvastatin Calcium Rosuvastatin Calcium TABLET ORAL 20251011 N/A ANDA ANDA207626 Umedica Laboratories USA Inc. ROSUVASTATIN CALCIUM 40 mg/1 1000 TABLET in 1 BOTTLE (60290-046-05)
13668-720-05 13668-720 HUMAN PRESCRIPTION DRUG Rosuvastatin Calcium Rosuvastatin Calcium TABLET ORAL 20230801 N/A ANDA ANDA207626 TORRENT PHARMACEUTICALS LIMITED ROSUVASTATIN CALCIUM 5 mg/1 500 TABLET in 1 BOTTLE (13668-720-05)
13668-720-10 13668-720 HUMAN PRESCRIPTION DRUG Rosuvastatin Calcium Rosuvastatin Calcium TABLET ORAL 20241220 N/A ANDA ANDA207626 TORRENT PHARMACEUTICALS LIMITED ROSUVASTATIN CALCIUM 5 mg/1 1000 TABLET in 1 BOTTLE (13668-720-10)
13668-720-90 13668-720 HUMAN PRESCRIPTION DRUG Rosuvastatin Calcium Rosuvastatin Calcium TABLET ORAL 20230801 N/A ANDA ANDA207626 TORRENT PHARMACEUTICALS LIMITED ROSUVASTATIN CALCIUM 5 mg/1 90 TABLET in 1 BOTTLE (13668-720-90)
13668-721-05 13668-721 HUMAN PRESCRIPTION DRUG Rosuvastatin Calcium Rosuvastatin Calcium TABLET ORAL 20230801 N/A ANDA ANDA207626 TORRENT PHARMACEUTICALS LIMITED ROSUVASTATIN CALCIUM 10 mg/1 500 TABLET in 1 BOTTLE (13668-721-05)
13668-721-10 13668-721 HUMAN PRESCRIPTION DRUG Rosuvastatin Calcium Rosuvastatin Calcium TABLET ORAL 20241220 N/A ANDA ANDA207626 TORRENT PHARMACEUTICALS LIMITED ROSUVASTATIN CALCIUM 10 mg/1 1000 TABLET in 1 BOTTLE (13668-721-10)
13668-721-90 13668-721 HUMAN PRESCRIPTION DRUG Rosuvastatin Calcium Rosuvastatin Calcium TABLET ORAL 20230801 N/A ANDA ANDA207626 TORRENT PHARMACEUTICALS LIMITED ROSUVASTATIN CALCIUM 10 mg/1 90 TABLET in 1 BOTTLE (13668-721-90)
13668-722-05 13668-722 HUMAN PRESCRIPTION DRUG Rosuvastatin Calcium Rosuvastatin Calcium TABLET ORAL 20230801 N/A ANDA ANDA207626 TORRENT PHARMACEUTICALS LIMITED ROSUVASTATIN CALCIUM 20 mg/1 500 TABLET in 1 BOTTLE (13668-722-05)
13668-722-10 13668-722 HUMAN PRESCRIPTION DRUG Rosuvastatin Calcium Rosuvastatin Calcium TABLET ORAL 20241220 N/A ANDA ANDA207626 TORRENT PHARMACEUTICALS LIMITED ROSUVASTATIN CALCIUM 20 mg/1 1000 TABLET in 1 BOTTLE (13668-722-10)
13668-722-90 13668-722 HUMAN PRESCRIPTION DRUG Rosuvastatin Calcium Rosuvastatin Calcium TABLET ORAL 20230801 N/A ANDA ANDA207626 TORRENT PHARMACEUTICALS LIMITED ROSUVASTATIN CALCIUM 20 mg/1 90 TABLET in 1 BOTTLE (13668-722-90)
13668-723-05 13668-723 HUMAN PRESCRIPTION DRUG Rosuvastatin Calcium Rosuvastatin Calcium TABLET ORAL 20230801 N/A ANDA ANDA207626 TORRENT PHARMACEUTICALS LIMITED ROSUVASTATIN CALCIUM 40 mg/1 500 TABLET in 1 BOTTLE (13668-723-05)
13668-723-10 13668-723 HUMAN PRESCRIPTION DRUG Rosuvastatin Calcium Rosuvastatin Calcium TABLET ORAL 20241220 N/A ANDA ANDA207626 TORRENT PHARMACEUTICALS LIMITED ROSUVASTATIN CALCIUM 40 mg/1 1000 TABLET in 1 BOTTLE (13668-723-10)
13668-723-30 13668-723 HUMAN PRESCRIPTION DRUG Rosuvastatin Calcium Rosuvastatin Calcium TABLET ORAL 20230801 N/A ANDA ANDA207626 TORRENT PHARMACEUTICALS LIMITED ROSUVASTATIN CALCIUM 40 mg/1 30 TABLET in 1 BOTTLE (13668-723-30)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2025 Drugfuture->U.S. FDA National Drug Code DataBase